Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lucentis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lucentis was produced by Novartis and Roche.

NHS wins legal fight with pharma over off-label Avastin

NHS wins legal fight with pharma over off-label Avastin and Novartis’ Lucentis  to treat wet AMD, claiming that it broke EU and UK laws governing medicines licensing. ... The cost implications are clear, as the court judgement showed: it says Avastin’s list price is around £28 per injection; Eylea

Allergan’s abicipar matches AMD blockbuster Lucentis in phase III

Allergan’s abicipar matches AMD blockbuster Lucentis in phase III Allergan and partner Molecular Partners say a pair of two studies of abicipar show that the drug is non-inferior to monthly dosing with Roche and Novartis’ blockbuster Lucentis (ranibizumab) when ... The new drug could halve the number of injections

Regeneron’s Dupixent and Praluent falls short

Regeneron’s Dupixent and Praluent falls short momentum. Eylea is already fending off pressure from Novartis’ Lucentis (ranibizumab) but faces more competition in the market from late-stage experimental drugs such as Novartis’ RTH258, as well as biosimilars ... of Lucentis.

The good, the bad and the ugly

The good, the bad and the ugly It hopes these measures will help offset Lucentis’ EU patent expiry in 2022.”. ... Regeneron remains the leading player, with 10% growth in 2017 thanks to superior data for Eylea against Lucentis.

It’s only money

It’s only money problem breached European Union competition rules - this ruling upheld a 2014 decision by Italy’s antitrust authority that the drugmakers colluded to boost sales of Lucentis by discrediting the cheaper Avastin

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...
APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...

Infographics